These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 25120615)

  • 1. Protective roles of erythropoiesis-stimulating proteins in chronic heart failure with anemia.
    Zhou S; Zhuang Y; Zhao W; Jiang B; Pan H; Zhang X; Peng H; Chen Y
    Exp Ther Med; 2014 Sep; 8(3):863-870. PubMed ID: 25120615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythropoiesis-stimulating agents for anaemia in chronic heart failure patients.
    Ngo K; Kotecha D; Walters JA; Manzano L; Palazzuoli A; van Veldhuisen DJ; Flather M
    Cochrane Database Syst Rev; 2010 Jan; (1):CD007613. PubMed ID: 20091643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of darbepoetin alfa on exercise tolerance in anemic patients with symptomatic chronic heart failure: a randomized, double-blind, placebo-controlled trial.
    Ponikowski P; Anker SD; Szachniewicz J; Okonko D; Ledwidge M; Zymlinski R; Ryan E; Wasserman SM; Baker N; Rosser D; Rosen SD; Poole-Wilson PA; Banasiak W; Coats AJ; McDonald K
    J Am Coll Cardiol; 2007 Feb; 49(7):753-62. PubMed ID: 17306703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ivabradine Improves Cardiac Function and Increases Exercise Capacity in Patients with Chronic Heart Failure.
    Pei H; Miao W; Xie WZ; Wang W; Zhao D; Su GH; Zhao Z
    Int Heart J; 2019 Jul; 60(4):899-909. PubMed ID: 31308326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythropoietin treatment in patients with chronic heart failure: a meta-analysis.
    van der Meer P; Groenveld HF; Januzzi JL; van Veldhuisen DJ
    Heart; 2009 Aug; 95(16):1309-14. PubMed ID: 19168472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythropoietin improves anemia exercise tolerance and renal function and reduces B-type natriuretic peptide and hospitalization in patients with heart failure and anemia.
    Palazzuoli A; Silverberg D; Iovine F; Capobianco S; Giannotti G; Calabrò A; Campagna SM; Nuti R
    Am Heart J; 2006 Dec; 152(6):1096.e9-15. PubMed ID: 17161060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of erythropoiesis stimulating therapy for anemia in chronic heart failure: A meta-analysis of randomized clinical trials.
    Kang J; Park J; Lee JM; Park JJ; Choi DJ
    Int J Cardiol; 2016 Sep; 218():12-22. PubMed ID: 27209352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency.
    Toblli JE; Lombraña A; Duarte P; Di Gennaro F
    J Am Coll Cardiol; 2007 Oct; 50(17):1657-65. PubMed ID: 17950147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mortality and morbidity reduction with Candesartan in patients with chronic heart failure and left ventricular systolic dysfunction: results of the CHARM low-left ventricular ejection fraction trials.
    Young JB; Dunlap ME; Pfeffer MA; Probstfield JL; Cohen-Solal A; Dietz R; Granger CB; Hradec J; Kuch J; McKelvie RS; McMurray JJ; Michelson EL; Olofsson B; Ostergren J; Held P; Solomon SD; Yusuf S; Swedberg K;
    Circulation; 2004 Oct; 110(17):2618-26. PubMed ID: 15492298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythropoietin in heart failure and other cardiovascular diseases: hematopoietic and pleiotropic effects.
    Manolis AS; Tzeis S; Triantafyllou K; Michaelidis J; Pyrros I; Sakellaris N; Kranidis A; Melita H
    Curr Drug Targets Cardiovasc Haematol Disord; 2005 Oct; 5(5):355-75. PubMed ID: 16248829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Once-monthly administration of darbepoetin alfa for the treatment of patients with chronic heart failure and anemia: a pharmacokinetic and pharmacodynamic investigation.
    Cleland JG; Sullivan JT; Ball S; Horowitz JD; Agoram B; Rosser D; Yates W; Tin L; Fuentealba P; Burton PB
    J Cardiovasc Pharmacol; 2005 Aug; 46(2):155-61. PubMed ID: 16044026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical benefits and risks associated with epoetin and darbepoetin in patients with chemotherapy-induced anemia: a systematic review of the literature.
    Ross SD; Allen IE; Henry DH; Seaman C; Sercus B; Goodnough LT
    Clin Ther; 2006 Jun; 28(6):801-31. PubMed ID: 16860166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anemia and mortality in heart failure patients a systematic review and meta-analysis.
    Groenveld HF; Januzzi JL; Damman K; van Wijngaarden J; Hillege HL; van Veldhuisen DJ; van der Meer P
    J Am Coll Cardiol; 2008 Sep; 52(10):818-27. PubMed ID: 18755344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of iron therapy in patients with chronic heart failure and iron deficiency: a systematic review and meta-analysis based on 15 randomised controlled trials.
    Zhang J; Hu S; Jiang Y; Zhou Y
    Postgrad Med J; 2020 Dec; 96(1142):766-776. PubMed ID: 32843482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of erythropoiesis-stimulating agents on heart failure patients with anemia: a meta-analysis.
    Zhang H; Zhang P; Zhang Y; Yan J; Dong P; Wang Y; Niu X
    Postepy Kardiol Interwencyjnej; 2016; 12(3):247-53. PubMed ID: 27625688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of erythropoiesis stimulating agents and intravenous (IV) iron in the cardio renal anemia syndrome.
    Silverberg DS
    Heart Fail Rev; 2011 Nov; 16(6):609-14. PubMed ID: 20865450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structured telephone support or telemonitoring programmes for patients with chronic heart failure.
    Inglis SC; Clark RA; McAlister FA; Ball J; Lewinter C; Cullington D; Stewart S; Cleland JG
    Cochrane Database Syst Rev; 2010 Aug; (8):CD007228. PubMed ID: 20687083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous iron alone for the treatment of anemia in patients with chronic heart failure.
    Bolger AP; Bartlett FR; Penston HS; O'Leary J; Pollock N; Kaprielian R; Chapman CM
    J Am Coll Cardiol; 2006 Sep; 48(6):1225-7. PubMed ID: 16979010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythropoiesis-stimulating protein support and survival.
    Crawford J
    Oncology (Williston Park); 2006 Jul; 20(8 Suppl 6):39-43. PubMed ID: 16925111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythropoietin as a treatment of anemia in heart failure: systematic review of randomized trials.
    Kotecha D; Ngo K; Walters JA; Manzano L; Palazzuoli A; Flather MD
    Am Heart J; 2011 May; 161(5):822-831.e2. PubMed ID: 21570510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.